Acasti Pharma Inc. (CVE:ACST – Get Free Report) shot up 1.8% during trading on Tuesday. The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Performance
The stock has a 50-day moving average price of C$0.58 and a two-hundred day moving average price of C$0.58. The stock has a market capitalization of C$18.19 million, a PE ratio of -1.21 and a beta of 1.22.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Further Reading
- Five stocks we like better than Acasti Pharma
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
